NDC 0378-1201
Sorafenib Tosylate
Sorafenib
Sorafenib Tosylate is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Mylan Pharmaceuticals Inc.. The primary component is Sorafenib Tosylate.
| Product ID | 0378-1201_347ec24f-101b-403d-a5bb-539a8afdfca5 |
| NDC | 0378-1201 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Sorafenib Tosylate |
| Generic Name | Sorafenib |
| Dosage Form | Tablet, Film Coated |
| Route of Administration | ORAL |
| Marketing Start Date | 2022-03-21 |
| Marketing Category | ANDA / |
| Application Number | ANDA207012 |
| Labeler Name | Mylan Pharmaceuticals Inc. |
| Substance Name | SORAFENIB TOSYLATE |
| Active Ingredient Strength | 200 mg/1 |
| Pharm Classes | Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2023-12-31 |